Canada· CA-DIN-02444038

MIFEGYMISO

A mifepriston, kombinationen product containing mifepristone + misoprostol, registered in Canada by LINEPHARMA INTERNATIONAL LIMITED.

ATC G03XB51

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedMIFEGYMISOATCG03XB51REGISTER NO.CA-DIN-02444038PACKS LISTED0CHECKEDOctober 1, 2026

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
MIFEPRISTONE + MISOPROSTOL
Manufacturer
LINEPHARMA INTERNATIONAL LIMITED
Country
Canada (CA)
ATC code
G03XB51
ATC class
Mifepriston, Kombinationen
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mifepriston, kombinationen in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mifepriston, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Medabon Combipack
  • Netherlands · Sunmedabon, Combinatieverpakking
  • Romania · Medabon Pachet Combinat

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0bb6a73-5308-486a-a946-a1695c087302
GET /v1/drugs/e0bb6a73-5308-486a-a946-a1695c087302?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02444038",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL",
    "BUCCAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "G03XB51",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "92881",
  "strengths": [
    "200 MG",
    "200 MCG"
  ],
  "ahfs_class": null,
  "substances": [
    "MIFEPRISTONE",
    "MISOPROSTOL"
  ],
  "product_categorization": null
}

See everything about mifepriston, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.